By 2029, the global market for cannabinoid-based pharmaceuticals will reach $50 billion.
Maxim Mikheev, PhD, MD, MSc
Advertisement
Articles by Maxim Mikheev, PhD, MD, MSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Dementia Increases Risk of COVID-19 Infection, Hospitalization for Older Patients
2
Pharmacists Provide Tailored Pneumococcal Vaccines to Patients With Down Syndrome
3
FDA Approves Lumateperone as Adjunct Therapy for Major Depressive Disorder
4
Most Favored Nation, Direct-to-Consumer Strategies Reshape US Pharma Landscape, Challenging Traditional Care
5
